Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 8/20 | 0.57 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.52 |
| ▸ | KLK1 | P06870 | 1/20 | 0.52 |
| ▸ | CLPP | Q16740 | 1/20 | 0.50 |
| ▸ | CCR2 | P41597 | 1/20 | 0.50 |
| ▸ | CCR9 | P51686 | 1/20 | 0.49 |
| ▸ | PPARG | P37231 | 4/20 | 0.49 |
| ▸ | CNR1 | P21554 | 4/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6432496 | 0.89 | F10 (0.62) | F10KLKB1KLK1CLPPCCR2 | |
| SCHEMBL6436698 | 0.89 | F10 (0.66) | F10KLKB1KLK1CCR2CNR1 | |
| SCHEMBL6436901 | 0.88 | F10 (0.69) | F10KLKB1KLK1CCR2PPARG | |
| SCHEMBL6432780 | 0.85 | F10 (0.56) | F10KLKB1KLK1CLPPCCR2 | |
| SCHEMBL6432441 | 0.84 | F10 (0.58) | F10KLKB1KLK1CLPPCCR2 | |
| SCHEMBL15926902 | 0.79 | F10 (0.60) | F10PPARG | |
| SCHEMBL6434179 | 0.79 | F10 (0.51) | F10KLKB1KLK1CCR2PPARG | |
| SCHEMBL7712483 | 0.78 | F10 (0.53) | F10KLKB1KLK1CCR2PPARG | |
| SCHEMBL8358655 | 0.78 | F10 (0.65) | F10CCR2CCR9PPARG | |
| SCHEMBL8357167 | 0.77 | PPARG (0.59) | F10CCR2CCR9PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1042287-B1 | INDOLE DERIVATIVES AS INHIBITORS OF FACTOR XA | AVENTIS PHARMA GMBH (DE) | 2005-04-20 | — | — | EP | disclosed |
| US-6337344-B1 | ANTICOAGULANTS AND ENZYME INHIBITORS FOR CARDIOVASCULAR DISORDERS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-01-08 | — | — | US | disclosed |